KnowlEdge Project –Concept, Methodology and Innovations for Artificial Intelligence in Industry 4.0

Real-World Surveillance of FDA-Cleared Artificial Intelligence Models: Rationale and Logistics.

Artificial Intelligence: The Future of Maxillofacial Prognosis and Diagnosis?

A power plant converts energy from a non-electric form to an electric one. Depending on the energy conversion, power plants are classified as minerals, nuclear, solar, geothermal, hydroelectric, and so on. The main goal is to perform this transformation as best as possible. Criteria of safety, efficiency, reliability and affordability are taken into account as benchmarks. The station consists of several units that generate and work together to meet electricity needs. For a fossil fuel power plant, each unit consists of three main components: a boiler, a turbine and a generator. The complexity of the operation is due to the variability of the load and high efficiency required in a wide range of operations. The main difficulties for the management task then arise due to the strong link between process variables and process nonlinearity. The purpose of this article is to analyze and develop a proposal for the introduction of artificial intelligence in the power industry of Ukraine. To achieve this goal, we will offer the following tasks: - analyze existing systems for the use of artificial intelligence in industry; - develop proposals for the introduction of artificial intelligence in the electricity system of Ukraine. In this study, methods of statistical, factorial, historical, comparative, logical, economic-mathematical and systems analysis, the method of expert assessments were used, which allowed to formulate proposals for the introduction of artificial intelligence in the power industry. Artificial neural networks are the first step towards a fundamentally new system of information analysis. They are mathematical and computer models that simulate the work of biological neurons, ie a system of interacting processes, built on the principle of connecting nerve cells of the human brain. It should be noted that they differ from conventional machine algorithms in the ability to learn, memorize and reproduce images, determine patterns, memorize and analyze information and obtain results. Output signals that arrive at the next processor and continue to be converted. Thus, artificial neurons form networks and layers in which connections are created, restored, maintained and destroyed by special signals. With regard to artificial intelligence, there is no generally accepted definition of artificial intelligence, therefore, by artificial intelligence we mean a machine system capable of learning using objective knowledge and experience, to solve creative problems like the human brain and inventive tasks, not going through options, build strategies and apply abstract concepts. Digitalization and artificial intelligence are penetrating most sectors of the economy, including the electricity sector. The digitalization of energy requires the development and widespread use of end-to-end technologies, including industrial Internet, components of robotics, wireless communications, artificial intelligence and others. Thus, artificial intelligence technologies have prospects for development. Of course, significant targeted funding is needed to achieve significant results. The interaction of research institutes and universities with business is very important, where artificial intelligence technologies are also being developed. Attention of the authorities and society, their understanding of the importance of the tasks facing countries to achieve the goal of implementing artificial intelligence. With regard to electricity, the integration of artificial intelligence into the industry will help optimize and increase efficiency in all aspects of energy production, transmission and consumption. It should be noted that the development of electricity is a step towards the development of other industries. That is why the transition to the digital industry is impossible without the digitalization and intellectualization of the power industry

Background: The topic of artificial Intelligence and its application in medicine has gained tremendous popularity, coinciding with advances in its technology. Breast cancer treatments vary, with surgery being one of them. In this review, we aim to evaluate artificial Intelligence’s ability to predict surgical outcomes, complications, and survival rates after breast cancer surgery by analyzing original research conducted over the last 5 years. Materials and Methods: A PubMed search was conducted by two authors from January 1, 2020, to April 13, 2025, using the keywords "Artificial Intelligence" and "Breast Surgery". After elimination, 14 of the 215 articles were full-text screened, and nine original articles were selected for inclusion in our review. Discussion: Artificial intelligence models and systems have had a significant impact on the medical field, and breast cancer surgery is no exception. Several original research studies have explored AI's ability to predict surgical outcomes and postoperative results. In this review, we focus on the postoperative aspects of breast cancer surgery and its application of artificial intelligence. Of the nine articles included in this paper, all reported multiple statistically significant results (p <0.05). Although no prospective research directly compares artificial intelligence with practicing physicians, artificial intelligence’s ability to accurately predict surgical outcomes, complications, and survival has shown higher accuracy and c-index than commonly used prediction methods, as reported in multiple studies. Conclusion: Artificial Intelligence can be a valuable asset in helping surgeons and medical doctors worldwide predict prognosis with improved systems and accuracy rates, even surpassing those of currently used conservative systems. There is a lack of information on PubMed regarding the comparison of these two aspects, particularly with larger sample sizes. More research should be conducted on this topic, particularly in comparing Artificial Intelligence systems and models with current systems and evaluation methods.

The Symposium on the Application of Artificial Intelligence in Industry was held in conjunction with the Sixth Pacific Rim International Conference on Artificial Intelligence (PRICAI-2000), Melbourne Australia, August 2000. It was the second of the Symposium series aiming to highlight actual applications of Artificial Intelligence in industry and to share and compare experiences in doing so. The Symposium brought together researchers and developers of applied Artificial Intelligence systems. The symposium is the leading forum in the Pacific Rim for the presentation of innovative applications of AI in industry.

Pharmacovigilance, the science of monitoring drug safety, plays a crucial role in identifying and mitigating adverse drug reactions (ADRs). However, underreporting in pharmacovigilance systems—estimated to have a median rate of 94 %—poses a significant threat to patient safety by hindering the detection of safety signals. The need to address these gaps is paramount, especially with the rising complexity of healthcare data. The advent of artificial intelligence (AI) and big data technologies offers promising solutions to overcome the limitations of traditional pharmacovigilance methods.The application of AI and machine learning (ML) technologies, including natural language processing (NLP) and deep learning, has the potential to revolutionize drug safety monitoring by automating the detection of ADRs from diverse data sources, such as electronic health records (EHRs), spontaneous reporting systems, and social media. These tools can process unstructured data and uncover patterns not easily identifiable through conventional approaches. Additionally, AI can enable real-time pharmacovigilance, which is especially critical in an era of increasing polypharmacy and diverse patient populations. AI-driven models are being utilized to detect drug-drug interactions (DDIs), predict ADRs, and enhance the overall efficiency of pharmacovigilance processes.Despite these advancements, several challenges remain. The performance of AI models is heavily dependent on the quality and quantity of data available. Inadequate or poorly curated datasets can lead to inaccurate ADR detection, particularly in resource-limited settings. Moreover, the heterogeneity of data sources necessitates robust AI models capable of integrating various types of data while ensuring accurate and reliable outputs. There is also a pressing need to address the transparency and explainability of AI models, as the opaque decision-making processes of current algorithms often impede their acceptance among pharmacovigilance professionals.Future directions must focus on improving the quality and standardization of datasets, advancing NLP techniques for better interpretation of clinical narratives, and developing explainable AI models. Regulatory frameworks should evolve to support AI deployment in pharmacovigilance, ensuring the establishment of best practices for AI implementation and the creation of large-scale, publicly available training datasets.Additionally, AI models should go beyond correlation-based approaches by integrating causal inference techniques, which will allow for a more accurate understanding of the relationship between drugs and ADRs. Human oversight will still be required to validate AI findings, but ongoing efforts to improve the robustness of AI systems will reduce dependency on manual interventions and scale the use of AI in pharmacovigilance.The integration of AI and big data in pharmacovigilance has the potential to transform drug safety monitoring, addressing many of the challenges posed by increasing data complexity and the need for real-time analysis. As these technologies continue to evolve, they promise to make pharmacovigilance more efficient, accurate, and comprehensive, thereby improving patient safety and rational drug use.

The secondary use of health data for training Artificial Intelligence (AI) models holds immense potential for advancing medical research and healthcare delivery. However, ensuring patient consent for such utilization is paramount to uphold ethical standards and data privacy. Patient informed consent means patients are fully informed about how their data will be collected, used, and protected, and they voluntarily agree to allow their data to be used for AI models. In addition to formal consent frameworks, establishing a social license is critical to foster public trust and societal acceptance for the secondary use of health data in AI systems. This study examines patient consent practices in this domain. In this scoping review, we searched Web of Science, PubMed, and Scopus. We included studies in English that addressed the core issues of interest, namely, privacy, security, legal, and ethical issues related to the secondary use of health data in AI models. Articles not addressing the core issues, as well as systematic reviews, meta-analyses, books, letters, conference abstracts, and study protocols were excluded. Two authors independently screened titles, abstracts, and full texts, resolving disagreements with a third author. Data was extracted using a data extraction form. After screening 774 articles, a total of 38 articles were ultimately included in the review. Across these studies, a total of 178 barriers and 193 facilitators were identified. We consolidated similar codes and extracted 65 barriers and 101 facilitators, which we then categorized into four themes: "Structure," "People," "Physical system," and "Task." We identified notable emphasis on "Legal and Ethical Challenges" and "Interoperability and Data Governance." Key barriers included concerns over privacy and security breaches, inadequacies in informed consent processes, and unauthorized data sharing. Critical facilitators included enhancing patient consent procedures, improving data privacy through anonymization, and promoting ethical standards for data usage. Our study underscores the complexity of patient consent for the secondary use of health data in AI models, highlighting significant barriers and facilitators within legal, ethical, and technological domains. We recommend the development of specific guidelines and actionable strategies for policymakers, practitioners, and researchers to improve informed consent, ensuring privacy, trust, and ethical use of data, thereby facilitating the responsible advancement of AI in healthcare.

Aim: The majority of machine learning (ML) models in healthcare are built on retrospective data, much of which is collected without explicit patient consent for use in artificial intelligence (AI) and ML applications. The primary aim of this study was to evaluate whether clinicians and scientific researchers themselves consent to provide their own data for the training of ML models. Materials and Methods: This survey was conducted through an anonymous online survey, utilizing platforms such as Telegram, LinkedIn, and Viber. The target audience comprised specific international groups, primarily Russian, German, and English-speaking, of clinicians and scientific researchers. These participants ranged in their levels of expertise and experience, from beginners to veterans. The survey centered on a singular, pivotal question: “Do You Consent to the Use of Your Biological and Private Data for Training Machine Learning and AI Models?” Respondents had the option to choose from three responses: “Yes” and “No”. Results: The survey was conducted in January 2024. A total of 119 unique and verified individuals participated in the survey. The results revealed that only 50% of respondents (63 persons) expressed consent to provide their own data for the training of ML and AI models. Conclusion: In the development of ML and AI models, particularly open-source ones, it is crucial to ascertain whether participants are willing to provide their private data. While ML algorithms can transform the nature of data, it is important to remember that the primary owner of this data is the individual. Our findings show that in 50% of the cases, even participants from scientific research and clinical backgrounds – individuals typically accountable for ensuring data quality in AI and ML model development – do not consent to the use of their data in AI and ML settings. This highlights the need for more stringent consent processes and ethical considerations in the utilization of personal data in AI and ML research.

Purpose The advent of digital technology has increased both the autonomy and complexity of intelligent machines. As data functionality becomes more advanced, the demand for machines to engage in teamwork alongside humans is rising, leading to a transformation of intelligent machines from tools to teammates. As such, human-autonomy team (HAT) is a new concept in digital transformation, and HAT-related research has driven the application and development of artificial intelligence in industry and production. This study explores the prospects of HAT in project management through a systematic literature review of published articles, highlighting current research themes and proposing directions for future research. Design/methodology/approach While the systematic literature review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, VOSviewer was employed to assist in keywords co-occurrence analysis to visualize the connections and networks of included articles. A total of 38 publications were retrieved from both Scopus and Web of Science databases to examine the annual publication trends, geographical distribution, research methods and keywords co-occurrence analysis. Findings The results revealed four mainstream research themes: (1) simulation of human–robotic system integration in project management, (2) algorithm design for human-centered artificial intelligence (AI), (3) the impact of digital transformation on teams towards agile project execution and (4) generative AI model for risk analysis in project management. Originality/value From both theoretical and practical implications, this study would deepen the role and effectiveness of HAT in project management strategies. The proposed framework suggested potential future directions such as (1) expanded testing scenarios, (2) human factors in evaluation criteria, (3) agile transition issues in HATs and (4) standards for AI model applications in project management. Ultimately, this study would foster a dialogue among researchers and practitioners by encouraging a synergistic approach to the implementation of HAT solutions in project settings.

This study evaluated if medical doctors could identify more hemorrhage events during chart review in a clinical setting when assisted by an artificial intelligence (AI) model and medical doctors' perception of using the AI model. To develop the AI model, sentences from 900 electronic health records were labeled as positive or negative for hemorrhage and categorized into one of 12 anatomical locations. The AI model was evaluated on a test cohort consisting of 566 admissions. Using eye-tracking technology, we investigated medical doctors' reading workflow during manual chart review. Moreover, we performed a clinical use study where medical doctors read two admissions with and without AI assistance to evaluate performance when using and perception of using the AI model. The AI model had a sensitivity of 93.7% and a specificity of 98.1% on the test cohort. In the use studies, we found that medical doctors missed more than 33% of relevant sentences when doing chart review without AI assistance. Hemorrhage events described in paragraphs were more often overlooked compared with bullet-pointed hemorrhage mentions. With AI-assisted chart review, medical doctors identified 48 and 49 percentage points more hemorrhage events than without assistance in two admissions, and they were generally positive toward using the AI model as a supporting tool. Medical doctors identified more hemorrhage events with AI-assisted chart review and they were generally positive toward using the AI model.

Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study

BackgroundAlthough capsule endoscopy (CE) is a crucial tool for diagnosing small bowel diseases, the need to process a vast number of images imposes a significant workload on physicians, leading to a high risk of missed diagnoses. This study aims to develop an artificial intelligence (AI) model and application based on convolutional neural networks that can automatically recognize various lesions in small bowel capsule endoscopy.MethodsThree small bowel capsule endoscopy datasets were used for AI model training, validation, and testing, encompassing 12 categories of images. The model’s performance was evaluated using metrics such as AUC, sensitivity, specificity, precision, accuracy, and F1 score to select the best model. A human-machine comparison experiment was conducted using the best model and endoscopists with varying levels of experience. Model interpretability was analyzed using Grad-CAM and SHAP techniques. Finally, a clinical application was developed based on the best model using PyQt5 technology.ResultsA total of 34,303 images were included in this study. The best model, MobileNetv3-large, achieved a weighted average sensitivity of 87.17%, specificity of 98.77%, and an AUC of 0.9897 across all categories. The application developed based on this model performed exceptionally well in comparison with endoscopists, achieving an accuracy of 87.17% and a processing speed of 75.04 frames per second, surpassing endoscopists of varying experience levels.ConclusionThe AI model and application developed based on convolutional neural networks can quickly and accurately identify 12 types of small bowel lesions. With its high sensitivity, this system can effectively assist physicians in interpreting small bowel capsule endoscopy images.Future studies will validate the AI system for video evaluations and real-world clinical integration.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12876-024-03482-7.

Quantum computing (QC) is not a futuristic notion in agriculture, though its full potential has yet to be realized. QC is an emerging field at the intersection of physics and computer science that holds immense potential to revolutionize various sectors, including agriculture production and artificial intelligence (AI) modeling. While QC is still in the early stages of development and practical applications within agriculture are not yet widespread, researchers are actively exploring its potential benefits in various agricultural domains, including crop optimization, livestock breeding, and environmental monitoring. QC harnesses the principles of quantum mechanics to perform computations using quantum bits or qubits, which can exist in multiple states simultaneously. Unlike classical computers, which rely on binary bits representing 0 or 1, quantum computers exploit phenomena such as superposition and entanglement to process information in parallel, potentially offering exponential speedup for certain types of problems. In agriculture production, particularly in animal science, QC offers promising avenues for optimizing processes and enhancing productivity. Quantum algorithms can analyze vast amounts of genomic data to improve breeding programs, leading to the development of more resilient and productive livestock breeds. Furthermore, QC can facilitate precision farming techniques by modeling complex environmental factors and animal behavior to optimize feeding strategies, disease management, and overall farm management practices. Moreover, QC can significantly benefit AI modeling by accelerating computations and enabling more efficient training of AI models. Quantum algorithms can enhance the performance of AI algorithms in various tasks, including pattern recognition, natural language processing, and predictive analytics. By leveraging quantum-enhanced optimization algorithms, AI models can achieve better convergence and accuracy, leading to more effective decision-making and problem-solving capabilities. While hybrid intelligent models also represent a novel frontier in agriculture, QC has the potential to expedite the merging of mechanistic and AI modeling paradigms, facilitating a more holistic understanding of complex systems in agriculture and beyond. By integrating mechanistic models, which describe the underlying physical processes, with AI models, which learn patterns from data, quantum computing can enable comprehensive simulations and predictions of agricultural systems. This fusion of modeling paradigms can lead to more accurate and robust predictions of crop yields, livestock performance, and environmental impacts, facilitating informed decision-making for farmers and policymakers. The application of QC in agriculture, however, requires interdisciplinary collaborations between physicists, computer scientists, agronomists/animal scientists, and AI researchers. These collaborations can drive the development of quantum algorithms tailored to agricultural applications, the integration of quantum-enhanced AI techniques into existing modeling frameworks, and the deployment of QC resources in real-world agricultural systems. Ultimately, harnessing the power of QC holds the potential to revolutionize agriculture production practices, including regenerative agriculture, and advance AI modeling capabilities, paving the way for a more sustainable and efficient agricultural industry.

Statement of problem: Artificial intelligence (AI) applications are increasingly used in restorative process. But existing dentistry restoration effectiveness as well as growth and IA applications have not yet been systematically analyzed or documented. Purpose: The goal of such comprehensive evaluation is to discover & assess the abilities associated with artificial intelligence models in restorative dentistry for the analysis of caries as well as vertical tooth fracture, evaluate margins in preparing tooth, and analyze reconstructive failures. Methods: A systematic electronic review of 5 databases was carried out: PubMed/ MEDLINE, World of Science, EMBASE, Scopus and Cochrane. The investigation was carried out manually as well. Research using AI models was chosen on the basis of 4 criterion: dental caries diagnostics, diagnostics, vertical tooth fracture, tooth preparation recognition, & cause of failure of restoration. Both researchers rated the quality of the study for Critical Appraisal Checklist for Quasi-Experimental Studies (nonrandomized experimental studies). The 3rd author was asked for resolving the dispute. Results: 34 researches were made the part of this analysis: from which 29 contains artificial intelligence techniques including the diagnostics or treatment related to caries and its causes according to sensitivity models, 2 to diagnose vertical tooth fractures, 1 to prepare the teeth. Among the studied analysis, the accuracy of caries diagnosis in the AI models was tested from 76-88.3%, sensitivity from 73-90%, as well as specificity from 61.5-93%. In the study, the accuracy of predicted caries ranges from 83.6-97.1%. The performed research showed the accuracy of the analysis of a vertical tooth fracture from 88.3-95.7%. The study, which uses AI models to find a destination, had details with the range of 90.6-97.4%. Conclusions: AI models are a powerful tool for diagnosing caries as well as vertical tooth fractures, recognizing preparation margins and predicting restoration failures. But, the dental use of AI models continues to evolve. More research is needed to evaluate the clinical effectiveness of artificial intelligence models in restorative dentistry. Keyword: Artificial intelligence, restorative dentistry, vertical tooth fractures.

Artificial intelligence for diabetic retinopathy screening in Africa